SHENZHEN RUYAN TECHNOLOGY CO., LTD. – Trademark Portfolio
Entity Type: 99
SHENZHEN RUYAN TECHNOLOGY CO., LTD. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 25 (Clothing) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include DAXIN, GOBOK, and ADIUPUL. The owner is based in SHENZHEN.
201-21,A,BLDG 5,TUSINCERE,333 LONGFEI AVE
HUANGGEKENG COMMUNITY,LONGCHENG ST LONGGANG DIST,
SHENZHEN 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
SHENZHEN RUYAN TECHNOLOGY CO., LTD.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does SHENZHEN RUYAN TECHNOLOGY CO., LTD. have?
SHENZHEN RUYAN TECHNOLOGY CO., LTD. has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does SHENZHEN RUYAN TECHNOLOGY CO., LTD. file in?
SHENZHEN RUYAN TECHNOLOGY CO., LTD. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 25 (Clothing), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are SHENZHEN RUYAN TECHNOLOGY CO., LTD.'s most well-known trademarks?
SHENZHEN RUYAN TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as DAXIN, GOBOK, and ADIUPUL. These are among 4 currently registered trademarks in the portfolio.
What is SHENZHEN RUYAN TECHNOLOGY CO., LTD.'s trademark registration success rate?
SHENZHEN RUYAN TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.